Some people experience dizziness, nausea, sleep disturbance, anxiety, or unusual sensations when they reduce or stop an antidepressant. The old version of this article used a broken news link and advised readers to try EFT, sauna, and vitamins instead of medication. Those suggestions do not have evidence as safe substitutes for an individual treatment plan. The important issue is that stopping can be difficult and deserves practical support.
What a controlled experiment showed
In a double-blind trial, researchers briefly interrupted selective serotonin reuptake inhibitor treatment by substituting placebo without participants knowing when the switch occurred. Abrupt interruption produced a pattern of physical and psychological symptoms in some participants (Interruption of SSRI treatment placebo-controlled trial). This helps establish that withdrawal symptoms are not merely a person's imagination, although the short experiment does not tell us how every long-term user will respond.
A later synthesis of randomized and observational studies found that symptoms were reported after both antidepressant discontinuation and placebo discontinuation. That matters because symptoms may also reflect expectations, illness changes, or unrelated events. The analysis still found a difference attributable to stopping antidepressants (Incidence of antidepressant discontinuation symptoms research synthesis). Severity, timing, and duration vary widely; an average figure cannot predict one person's experience.
What helps when someone wants to stop?
The safest first step is a review with the prescriber of why the drug was started, whether it still helps, previous attempts to reduce it, and the person's current stability. The NICE depression guidance advises reducing the dose in stages and adjusting the pace to symptoms. It recognizes that some people need more support after a difficult previous attempt. Skipping doses or stopping suddenly can make it harder to tell withdrawal from a return of depression or anxiety.
Non-drug support can matter during this process. Psychological therapy, regular contact with a trusted clinician, sleep routines, and help from family or friends may make changes easier to manage. In the REDUCE cluster trial, adding online and telephone support to a practitioner review did not significantly increase the rate of stopping, but it did not worsen depression outcomes (REDUCE trial of support for antidepressant discontinuation). Support is useful, but no single method guarantees a successful taper.
People who feel severely depressed, unsafe, or suicidal need urgent help. For everyone else, the useful message is that discontinuation is possible for many people, withdrawal symptoms deserve to be taken seriously, and a flexible, supervised taper is preferable to a dramatic promise that a supplement or technique will replace care.
